Stable CHO Cell Lines Designed for Biologics Success
Speed, Quality, and Scalability
Our CHO cell line development approach combines advanced screening methodologies with data-driven selection criteria to identify clones with the productivity, stability, and product quality attributes required for long-term success. By evaluating critical performance characteristics early, we help accelerate biologics development timelines, improve manufacturing economics and reduce risk during scale-up and commercialization.
